Demographic, clinical, and laboratory parameters
| Gold | HCQ | ||||||
| 0 months | 12 months | Wilcoxon | 0 months | 12 months | Wilcoxon | ||
| Patients (n) | 49 | 25 | 51 | 35 | |||
| Age (y) | 62 (30–80) | 59 (33–78) | |||||
| Male:female | 18:31 | 10:41 | |||||
| Disease duration (y) | 6 (1–37) | 8 (1–40) | |||||
| Weight (kg) | 66.8 (47.0–107.0) | 64.6 (41.4–87.5) | |||||
| ESR (mm/1st h) | 63 (8–130) | 40 (3–86) | p=0.0013 | 53 (10–110) | 31 (8–102) | p=0.0001 | |
| CRP (IU/l) | 55 (0–222) | 19 (0–135) | p=0.019 | 41 (0–154) | 15 (0–118) | p=0.005 | |
| Pain score (VAS) | 50 (10–100) | 45 (5–100) | p=0.085 | 50 (0–100) | 38 (0–95) | p=0.132 | |
| Articular index | 12 (2–42) | 6 (0–31) | p=0.088 | 12 (0–42) | 5 (0–24) | p=0.0001 | |
Median and ranges are shown. No significant changes between the groups at outset (Mann–Whitney).